| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 220 |
| 1 | INFLIXIMAB | 219 |
| 2 | ETANERCEPT | 216 |
| 3 | METHOTREXATE SODIUM | 214 |
| 4 | SULFASALAZINE | 212 |
| 5 | LEFLUNOMIDE | 209 |
| 6 | TOCILIZUMAB | 206 |
| 7 | ABATACEPT | 205 |
| 8 | METHOTREXATE | 201 |
| 9 | RITUXIMAB | 198 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FEBUXOSTAT TABLETS 40 MG | 116 | 0.0179 |
| 1 | CANNABIS SATIVA | 13 | 0.0157 |
| 2 | DIMENHYDRINATE | 115 | 0.0140 |
| 3 | GOLD | 47 | 0.0110 |
| 4 | TETRACAINE HYDROCHLORIDE | 1 | 0.0108 |
| 5 | FEBUXOSTAT | 129 | 0.0102 |
| 6 | DICLOFENAC POTASSIUM TABLETS | 28 | 0.0081 |
| 7 | ADALIMUMAB-ADAZ | 157 | 0.0065 |
| 8 | COLCHICINE | 127 | 0.0055 |
| 9 | DICLOFENAC POTASSIUM | 28 | 0.0049 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 224 |
| 1 | Aminosalicylate [EPC] | 212 |
| 2 | Antirheumatic Agent [EPC] | 209 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 207 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 205 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 201 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 198 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 166 |
| 8 | Corticosteroid [EPC] | 160 |
| 9 | Vitamin B12 [EPC] | 145 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Alkaloid [EPC] | 127 | 0.0055 |
| 1 | Antirheumatic Agent [EPC] | 209 | 0.0023 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 207 | 0.0021 |
| 3 | Aminosalicylate [EPC] | 212 | 0.0020 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 205 | 0.0019 |
| 5 | Interleukin-12 Antagonist [EPC] | 127 | 0.0016 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 91 | 0.0010 |
| 7 | Interleukin-23 Antagonist [EPC] | 127 | 0.0009 |
| 8 | Phosphodiesterase 4 Inhibitor [EPC] | 130 | 0.0009 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 129 | 0.0009 |